A detailed history of Fmr LLC transactions in Merus N.V. stock. As of the latest transaction made, Fmr LLC holds 2,810,935 shares of MRUS stock, worth $270 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
2,810,935
Previous 7,490,377 62.47%
Holding current value
$270 Million
Previous $394 Million 32.83%
% of portfolio
0.01%
Previous 0.02%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 13, 2025

SELL
$52.33 - $94.15 $245 Million - $441 Million
-4,679,442 Reduced 62.47%
2,810,935 $265 Million
Q2 2025

Aug 14, 2025

BUY
$34.89 - $62.42 $18.3 Million - $32.7 Million
523,463 Added 7.51%
7,490,377 $394 Million
Q1 2025

May 12, 2025

BUY
$39.01 - $49.16 $2.63 Million - $3.31 Million
67,393 Added 0.98%
6,966,914 $293 Million
Q4 2024

Feb 13, 2025

BUY
$41.45 - $54.5 $1.06 Million - $1.39 Million
25,595 Added 0.37%
6,899,521 $290 Million
Q3 2024

Nov 13, 2024

BUY
$47.19 - $58.84 $30.6 Million - $38.2 Million
648,994 Added 10.43%
6,873,926 $343 Million
Q2 2024

Aug 13, 2024

BUY
$39.81 - $60.2 $182 Million - $275 Million
4,562,387 Added 274.42%
6,224,932 $368 Million
Q1 2024

May 13, 2024

BUY
$28.03 - $51.82 $26.1 Million - $48.3 Million
932,092 Added 127.6%
1,662,545 $74.9 Million
Q4 2023

Feb 13, 2024

SELL
$20.06 - $28.66 $892,670 - $1.28 Million
-44,500 Reduced 5.74%
730,453 $20.1 Million
Q3 2023

Nov 13, 2023

BUY
$20.13 - $27.29 $3.63 Million - $4.92 Million
180,397 Added 30.34%
774,953 $18.3 Million
Q2 2023

Aug 11, 2023

BUY
$18.33 - $27.18 $395,927 - $587,088
21,600 Added 3.77%
594,556 $15.7 Million
Q1 2023

May 11, 2023

BUY
$14.25 - $20.5 $1.4 Million - $2.01 Million
98,147 Added 20.67%
572,956 $10.5 Million
Q4 2022

Feb 13, 2023

SELL
$12.8 - $23.66 $1.03 Million - $1.91 Million
-80,777 Reduced 14.54%
474,809 $7.35 Million
Q3 2022

Nov 10, 2022

SELL
$18.64 - $28.93 $1.4 Million - $2.17 Million
-74,900 Reduced 11.88%
555,586 $11.1 Million
Q1 2022

May 13, 2022

SELL
$23.58 - $30.91 $1.07 Million - $1.4 Million
-45,200 Reduced 6.69%
630,486 $16.7 Million
Q4 2021

Feb 14, 2022

BUY
$20.0 - $32.29 $8.58 Million - $13.9 Million
429,086 Added 174.0%
675,686 $21.5 Million
Q2 2021

Aug 13, 2021

BUY
$20.0 - $25.48 $4.93 Million - $6.28 Million
246,600 New
246,600 $5.2 Million

Others Institutions Holding MRUS

About Merus N.V.


  • Ticker MRUS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,878,200
  • Market Cap $4.4B
  • Description
  • Merus N.V., a clinical-stage immuno-oncology company, engages in the discovery and development of bispecific antibody therapeutics in the Netherlands. Its bispecific antibody candidate pipeline includes Zenocutuzumab (MCLA-128), which is in a phase 2 clinical trials for the treatment of patients with metastatic breast cancer, as well as in Phase...
More about MRUS
Track This Portfolio

Track Fmr LLC Portfolio

Follow Fmr LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fmr LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fmr LLC with notifications on news.